Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
3D Systems has secured full-scope European Union Medical Device Regulation (EU MDR) certification, authorizing the launch of its NextDent Jetted Denture Solution across European markets targeted for summer 2026. Building on its 2025 US launch success, this move expands the company's digital dentistry footprint into significant European markets. The…
YY Group Holding Limited announced its estimated total assets of approximately $34.3 million ($8.03 per share) and net assets of approximately $13.6 million ($3.18 per share) for fiscal year 2025, reflecting preliminary unaudited results. The company accelerated growth via AI and robotics integration, secured major multi-year contracts internationa…
Verisk and APCIA released preliminary 2025 U.S. property and casualty insurance underwriting results showing a significant improvement with a $63 billion net underwriting gain, up from $23 billion in 2024. The strong performance was driven primarily by an unusually low level of catastrophe losses, particularly a sharp decline in hurricane-related c…
SL Green Realty Corp. refinances One Madison Avenue with a $1.65 billion fixed-rate loan at 5.81%, replacing its previous $1.25 billion construction loan. The transaction, led by Wells Fargo and featuring major banks, is oversubscribed and reflects strong investor demand for high-quality office properties despite market volatility. The refinancing …
U.S. equity futures climbed Wednesday morning as markets weighed reports that mediators could organize peace talks between the U.S. and Iran. Growing hopes for a resolution to the month-long conflict coincided with a drop in oil prices and mixed corporate headlines that pushed energy shares lower while lifting travel, mining and select technology n…
IMUNON announced updated final data from its Phase 2 OVATION 2 trial showing that treatment with IMNN-001 combined with standard chemotherapy significantly improved median overall survival in women with newly diagnosed advanced ovarian cancer, especially when combined with PARP inhibitors. Enrollment in the pivotal Phase 3 OVATION 3 trial is ahead …
UK headline inflation remained at 3.0% year-over-year in February, unchanged from January, while core inflation rose to 3.2%. Goods and services components diverged, with core goods accelerating and services easing, and consumer inflation expectations have jumped. Barclays warns that recent energy developments limit the forward usefulness of Februa…
Bank of America client flow data for last week shows a strong, concentrated shift into technology stocks while overall equity flows weakened. The S&P 500 declined 5.8% amid substantial single-stock selling and ETF outflows, yet tech recorded the largest inflows in BofA's records going back to 2008. Institutional and private clients largely sold, wh…
Morgan Stanley moved its stance on European energy stocks to Attractive from In-Line, arguing that the disruption to flows through the Strait of Hormuz represents a structural break that supports a longer commodity upswing and a tilt toward higher-beta energy companies. The bank raised oil and gas price assumptions, materially upgraded earnings for…
UBS economist Arend Kapteyn says the global economy today is considerably less exposed to an oil price shock than during the 1970s. Despite elevated crude prices and recent supply disruptions, oil spending as a share of GDP has declined markedly since 1974, reducing potential macroeconomic strain even if prices rise to $100 per barrel.
Safe Pro Group Inc., a Nasdaq-listed company specializing in AI-enabled defense and security solutions, announced the appointment of Brian Mack, former Anduril Senior Business Development Director and Retired U.S. Army Officer, to its Strategic Advisory Board. Mack brings extensive defense acquisition expertise and a strong network within the U.S. …
Liberty Energy Inc. saw its stock drop after unveiling a proposed private placement of $450.0 million in convertible senior notes due 2032, with an underwriter option for an additional $50.0 million. The notes are unsecured senior obligations, pay semiannual interest starting September 1, 2026, and include provisions for conversion, redemption and …
CDT Equity Inc. (NASDAQ: CDT) announced a 1-for-25 reverse stock split effective March 26, 2026. This corporate action reduces the number of outstanding shares to roughly 4.72 million, with no change in the par value per share. The move, approved by both the board and shareholders, intends to adjust the share structure and maintain listing standard…
Linkers Industries Limited (Nasdaq: LNKS) announced a non-binding Memorandum of Understanding to acquire up to 29% equity in LPW Electronics Co. Ltd., a wire harness manufacturer in Thailand, increasing its stake to 49%. The acquisition aims to boost Linkers' manufacturing capacity, optimize economies of scale, and broaden its customer base, suppor…
Aemetis, Inc. announced that CEO Eric McAfee received the 2026 William C. Holmberg Memorial Award for Lifetime Achievement in the Bioeconomy. The award honors McAfee's longstanding leadership and contributions to renewable fuels and bioeconomy innovation. Aemetis is actively expanding its renewable natural gas, biofuels, sustainable aviation fuel, …
Purple Biotech announced a collaboration with AI-driven drug discovery company Converge Bio to accelerate and optimize its next-generation tri-specific antibody platform aimed at cancer treatment. The partnership leverages Converge Bio's generative AI technology to speed up molecule design, improve candidate quality, and expand the company's immuno…
ProMIS Neurosciences completed enrollment of 144 patients in its PRECISE-AD Phase 1b trial for Alzheimer’s disease, with positive safety results to date and anticipated interim data in Q3 2026 and top-line results in early 2027. The company secured up to $175 million in financing ensuring cash runway through 2027, accelerating development of a subc…
AEON Biopharma announced positive feedback from the FDA following their January 2026 Biosimilar Biological Product Development Type 2a meeting regarding the analytical similarity strategy for ABP-450, their biosimilar candidate to BOTOX®. The FDA recognized the scientific challenges but supported AEON's analytical approach under the 351(k) biosimil…
Catheter Precision, Inc. (NYSE American: VTAK) announced the expansion of its Flyte subsidiary's Vision Jet-powered Hops platform, aimed at creating a scalable, high-frequency short-haul regional travel solution. Flyte operates Cirrus Vision Jets optimized for under-500-mile routes, offering safety features like full-aircraft parachutes and autonom…
Aduro Clean Technologies Inc. has entered into a professional agreement with Water Tower Research LLC to receive research coverage and strategic investor engagement services aimed at increasing the company's visibility within institutional investment communities in the U.S. and internationally. The contract includes production of content and distri…
Avalyn Pharma announced peer-reviewed data from its Phase 1b ATLAS trial demonstrating that improvements in quantitative lung imaging correlate with better lung function and quality of life in patients with idiopathic pulmonary fibrosis treated with AP01. The findings mark the first dataset linking antifibrotic therapy imaging with clinical outcome…
Innovation Beverage Group Ltd. (Nasdaq: IBG) announced it has acquired a 51% controlling stake in Texas-based BlockFuel Energy Inc. This acquisition is a significant milestone toward a proposed merger that will create a rising oil producer and power generation company focusing on US onshore oil and gas operations and power generation for high-perfo…
ProQR Therapeutics announced a virtual investor and analyst event on April 8, 2026, to showcase its expanding RNA editing pipeline based on its proprietary Axiomer™ technology. The company plans to provide updates on the lead AX-0810 program targeting cholestatic diseases with anticipated initial Phase 1 data in the first half of 2026, unveil AX-08…
Incannex Healthcare has entered a partnership with the American Academy of Sleep Medicine Foundation to sponsor research in sleep apnea, reflecting its commitment to the field as it advances its lead investigational oral combination therapy, IHL-42X. The company recently achieved strong Phase 2 clinical results and received FDA Fast Track designati…
authID announced a strategic OEM partnership with a disruptive digital identity and continuous background screening tech company to embed its biometric identity verification and authentication technology into the partner's platform. This collaboration aims to provide organizations with reusable digital identity credentials that enable secure onboar…
